PepGen Reports 46.5% Splicing Correction in DM1 Trial
PepGen's 10 mg/kg cohort achieved 46.5% mean splicing correction. Results from the fully enrolled 12.5 mg/kg cohort are due in 2027, while $104.8 million supports operations into 2028.
Topic
Biotech
Topic
Biotech
VectorY Raises €74.5 Million to Push ALS Antibody Into Late Readout
VectorY Therapeutics raised €74.5 million from new and returning investors to fund the final PIONEER-ALS readout for VTx-002 and…
ImmunityBio revenue rises 53% as losses and spending expand
ImmunityBio reported $48.7 million in third-quarter product revenue, up 53%, as ANKTIVA adoption expanded. Cash reached $334.3 mi…
Moderna posts $162 million profit, lifts 2026 revenue outlook
Moderna returned to quarterly profit with $162 million in net income, raised 2026 revenue growth guidance to 15%-25% and ended Se…
Norway's Vitroscope Raises $7 Million to Keep Living Tissue Under Flow
Trondheim biotech Vitroscope raised $7 million to roll out vitro.alive and validate vitro.scale, a 96-experiment perfusion system…
Alethio Therapeutics Raises $90M Series A for Blood Cancer Drugs
Sofinnova Partners and RA Capital co-led a $90M Series A in Oxford spinout Alethio Therapeutics to move blood cancer drug ATX-011…
ArrayPatch Closes €3.2M Seed Round for Polymer-Free Microneedle Patches
Cork-based ArrayPatch has closed a €3.2M seed round led by WakeUp Capital and Lakeside Capital to push its polymer-free GLP-1 mic…
Re:Build Lands $2.1 Billion; Kalshi valued at $40 Billion
Re:Build raised $2.1 billion and Kalshi hit a $40 billion valuation as manufacturing, robotics and AI startups pulled in roughly…
UK biotech funding hits £2.8bn as AI deals reshape sector
UK biotech venture funding rose 44% to £270m in Q3, lifting 2025 investment to £2.8bn — the strongest year since 2021 — despite a…
Peak XV, Lightspeed, Activate Circle Half a Dozen Indian AI Startups
Peak XV, Lightspeed and General Catalyst are in advanced talks to back six Indian AI startups, with deals of $3-10 million across…
DropGenie Lands $5M Seed+ to Scale Gene-Editing in Scarce Patient Cells
DropGenie raised $5M in Seed+ funding from BDC Thrive, Skeleton Key, Merck's GHI Fund and others to scale a gene-editing platform…